# Chloral Hydrate

## Clodrin 100mg/mL 30mL oral solution

| 藥物代碼 | LCLO |
| :--- | :--- |
| 適應症 | Sedation, mechanically-ventilated patients OR sedation, procedural \(eg, echocardiogram or EEG\). |
| 副作用 | Central nervous system: Abnormal gait, ataxia, confusion, delirium, dizziness, drowsiness, hallucinations, hangover effect, malaise, nightmares, paradoxical excitation, somnambulism, vertigoDermatologic: Skin rash \(including erythema, eczematoid dermatitis, urticaria, scarlatiniform exanthems\)Endocrine & metabolic: Acute porphyria, ketonuriaGastrointestinal: Diarrhea, flatulence, gastric irritation, nausea, vomitingHematologic & oncologic: Acute porphyria, eosinophilia, leukopenia |
| 禁忌 | Marked liver or kidney impairment, severe heart disease, Severe gastritis, esophagitis, gastric ulcer or duodenal ulcer, Purpura, Allergic to Chloral hydrate or any component of the formulation, Patients with life safety due to risk of respiratory obstruction or disabled Patients with severe obstructive sleep apnea |
| 藥物保存方式 | 密封,25℃以下 |
| 用法用量 | The sedative drug used before the non-painful procedure for children must be carried out in a medical institution and properly monitored. The dosage of medication must be strictly controlled according to different ages and weights of children. Electroencephalogram \(EEG\): Infants \(1 month to &lt;1 year\) and children: 25-50 mg/kg orally. The total maximum dose does not exceed 100mg/kg and infants do not exceed 1g, children do not exceed 2g. Sedation before painless examination or treatment \(administered 30-60 minutes before process\): Infants \(1 month to &lt;1 year\): 30-50 mg/kg orally. The total maximum dose does not exceed 100 mg/kg and the infant does not exceed 1 g. Children: 50-60mg/kg orally, if necessary, an additional 10-20mg/kg can be given after 30 minutes. The total maximum dose does not exceed 100 mg/kg and the child dose does not exceed 2 g. |
| 肝功能異常 | 需 調 整 劑 量  \[仿單\]明顯肝功能損害者禁用 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | No \(Limited\) Human Data - no relevant animal data |
| 附帶說明 | 仿單未有相關記載 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | 仿單未有相關記載 |
| 注射劑給藥建議途徑 | PO |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 請密封儲存於 25℃以下，毋須冰存並避免陽光直射。 開封後之保存期限為 30 天，儲存溫度為 25℃，未使用完應丟棄。 |

